10x Genomics
TXG Healthcare Health Information Services
10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS fell 150.0% and free cash flow fell 4.61%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow TXG
10x Genomics (TXG) P/E ratio
10x Genomics has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 26 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| TXG 10x Genomics | n/m |
| HQY HealthEquity, Inc. compare | 33.0× |
| BTSG BrightSpring Health Services, Inc. compare | 34.0× |
| DOCS Doximity, Inc. compare | 34.8× |
| WAY Waystar Holding Corp. compare | 38.0× |
| HNGE Hinge Health Inc. compare | 73.5× |
| PRVA Privia Health Group, Inc. compare | 102× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)